Eagle Pharmaceuticals, Inc.

STATE STREET CORP EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/14/2024

Shares

35,820

Value ($000)

134

Weight

0.0%

2014 Q1 - 2024 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/14/2024	134	0.0%	35,820	9/30/2024
2024 Q2	8/14/2024	201	0.0%	35,820	6/30/2024
2024 Q1	5/15/2024	1,120	0.0%	213,667	3/31/2024
2023 Q4	2/14/2024	1,164	0.0%	222,594	12/31/2023
2023 Q3	11/14/2023	3,277	0.0%	207,771	9/30/2023
2023 Q2	8/14/2023	4,621	0.0%	237,712	6/30/2023
2023 Q1	5/15/2023	11,431	0.0%	402,918	3/31/2023
2022 Q4	5/15/2023	27,828	0.0%	952,026	12/31/2022
2022 Q3	11/15/2022	26,730	0.0%	1,011,747	9/30/2022
2022 Q2	8/15/2022	34,471	0.0%	775,860	6/30/2022
2022 Q1	5/16/2022	35,429	0.0%	715,884	3/31/2022
2021 Q4	2/14/2022	36,063	0.0%	708,224	12/31/2021
2021 Q3	11/15/2021	39,545	0.0%	708,945	9/30/2021
2021 Q2	8/16/2021	31,577	0.0%	737,786	6/30/2021
2021 Q1	7/9/2021	33,500	0.0%	802,584	3/31/2021
2020 Q4	2/16/2021	37,913	0.0%	814,101	12/31/2020
2020 Q3	11/10/2020	33,774	0.0%	795,055	9/30/2020
2020 Q2	8/14/2020	37,415	0.0%	779,797	6/30/2020
2020 Q1	6/19/2020	28,772	0.0%	625,470	3/31/2020
2019 Q4	2/6/2020	36,684	0.0%	610,591	12/31/2019
2014 Q1	5/15/2014	271	0.0%	21,290	3/31/2014